查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球 IVF 市場：市場規模、佔有率、趨勢：按產品、設備、程序、週期、最終用戶 - 預測至 2029 年
市場調查報告書
商品編碼
1531518

全球 IVF 市場：市場規模、佔有率、趨勢：按產品、設備、程序、週期、最終用戶 - 預測至 2029 年

In Vitro Fertilization Market Size, Share & Trends by Product, Equipment, Procedure, Cycle, End-user - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 281 Pages | 訂單完成後即時交付

價格

全球 IVF 市場規模預計將從 2024 年的 9.49 億美元增至 2029 年的 16.5 億美元，預測期內複合年成長率為 11.7%。

從輔助生殖技術的改進以提高治療效果，到擴大醫療保健中不孕症服務的覆蓋範圍，再到配備專門從事生殖健康問題的高素質專業人員的專業診所的可用性等等，都在推動需求。一個阻礙因素是治療費用高昂，這可能使許多人和夫婦無法負擔。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（百萬美元）
部分 按產品、設備、程序、週期、最終用戶、地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

關於成功 IVF 治療所必需的設備類型及其開發。簡而言之，體外受精主要依靠專門的工具，如胚胎培養箱、用於顯微授精的顯微操作器以及用於保存胚胎和配子的冷凍保存系統。先進的成像技術可以在可行的胚胎選擇中實現延時成像，而基因篩檢領域的下一代定序工具可以改善胚胎品質評估。隨著醫療技術的進步，體外受精設備也正在進行技術革新。像這樣的創新研究已經制度化，並得到了更大的行業計劃的支持，並繼續提高成功率和整體患者治療結果。從確保安全性和有效性的監管標準，到擴大不孕症治療覆蓋範圍的醫療保健政策，再到在全球範圍內提供體外受精設備的最佳作用，這些結合起來有助於技術的發展，正在為更多人推動生殖解決方案的最新創新需要不孕症治療。

該報告考察了全球 IVF 市場，並按產品、設備、程序、週期、最終用戶、地區和進入市場的公司概況總結了趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 價值鏈分析
  • 影響客戶業務的趨勢/干擾
  • 價格分析
  • 波特五力分析
  • 專利分析
  • 貿易資料分析
  • 2024-2025年重大會議和活動
  • 主要相關人員和採購標準
  • 未滿足的需求
  • 生態系分析
  • 供應鏈分析
  • 技術分析
  • 案例研究分析
  • 監管狀況
  • 投資金籌措場景
  • 退款場景
  • 產生人工智慧對 IVF 市場的影響

第6章 IVF市場（依產品）

  • 介紹
  • 裝置
  • 試劑和介質
  • 配件

第7章 IVF市場（按週期）

  • 介紹
  • 新的非捐助者
  • 冷凍非捐贈者
  • 冷凍供體
  • 新捐款者

第8章 IVF市場（依程序）

  • 介紹
  • 傳統體外受精
  • 卵細胞質內單一精蟲顯微注射術體外受精
  • 微創體外受精
  • 用捐贈卵子進行體外受精
  • 其他

第9章 IVF 市場（依最終用戶）

  • 介紹
  • 生育診所及試管受精中心
  • 醫院和外科中心
  • 研究所
  • 冷凍庫

第10章試管嬰兒市場（按地區）

  • 介紹
  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 中東/非洲

第11章競爭格局

  • 概述
  • 主要參與企業的策略/秘密
  • 收益分析
  • 市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 企業價值評估及財務指標
  • 品牌/產品比較
  • 競爭場景

第12章 公司簡介

  • 主要參與企業
    • COOPERSURGICAL, INC.
    • VITROLIFE
    • COOK MEDICAL INC.
    • HAMILTON THORNE
    • THERMO FISHER SCIENTIFIC INC.
    • FUJIFILM IRVINE SCIENTIFIC
    • KITAZATO CORPORATION
    • ESCO MICRO PTE. LTD.
    • FERTIPRO NV
    • GENEA BIOMEDX
    • NIKON CORPORATION
    • OLYMPUS
    • CORNING INCORPORATED
    • CARL ZEISS MICROSCOPY GMBH
    • EPPENDORF
    • MEIJI TECHNO
    • LEICA MICROSYSTEMS
    • GE HEALTHCARE
  • 其他公司
    • BIOIMAGER
    • ALLWIN MEDICAL DEVICES
    • SHANGHAI UNICORN MEDICAL TECHNOLOGY
    • GYNEMED
    • INVITROCARE
    • IVFTECH
    • LABIVF
    • MONASH BIOTECH
    • HUNTER SCIENTIFIC
    • CALIBRE SCIENTIFIC
    • SHIVANI SCIENTIFIC INDUSTRIES（P）LTD.
    • MINITUBE HUMAN ART

第13章附錄

Product Code: MD 4467

The global in vitro fertilization market is projected to reach USD 1,650 million by 2029 from USD 949 million in 2024, growing at a CAGR of 11.7% during the forecast period. The projected market growth for in vitro fertilization is supported by the convergence of benefits. In Vitro Fertilization convergence of advantages supports the projected market growth of this industry. In vitro fertilization: A host of factors drives the demand, from improvements in assisted reproductive technologies improving treatment efficacy to expanded fertility service coverage by healthcare and availability of specialized clinics with highly qualified professionals specialized in health reproduction issues. The restraints are the high cost of the procedure that may put treatment beyond the reach of too many people or even couples..

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsProduct, Cycle, Procedure, End User and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa

"IVF EquipmentsS to register largest market share in 2022-2029."

The kinds of equipment that are essential to dispensation of IVF treatment and their development for its success. In a nutshell, IVF mainly relies upon specialized tools such as embryo culture incubators, micromanipulators used for ICSI, and the cryopreservation systems used in the storage of embryos and gametes. Advanced imaging technologies allow for time-lapse imaging in the selection of viable embryos, and next-generation sequencing tools in the field of genetic screening improve embryo quality assessment. Together with advances in medical technology, IVF equipment is undergoing innovation. Such innovative research is institutionalized and underpinned by larger industrial initiatives that continue to drive success rates and overall patient outcomes. From the regulatory standards ensuring safety and effectiveness, to the healthcare policies increasing coverage for infertility treatments, and the highest role in making IVF equipment available worldwide, these combine to drive technological evolution and put the newest innovations in reproductive solutions before more and more people in need of fertility assistance..

"Fertility Clinics & IVF Centres segment held the largest share of in vitro fertilization market in 2023, by End-user."

Based on the end-user, the in vitro fertilization market is segmented into fertility clinics & IVF centres, hospitals, surgical centers, and cryobanks. In the year 2023, the global in vitro fertilization market was dominated by hospitals and clinics. The growth of the hospital & clinic segment is getting accelerated.

By speeding up the problems of infertility, increasing IVF procedures for early detection of possible complications, and introducing continuous advanced technologies.

"Fresh non donor to register highest growth rate in the market during the forecast period."

By Cycle Fresh Donor, Frozen Donor, Frozen Non Donor, Fresh Non Donor. Fresh non-donor is likely to grow at the fastest rate in the period from 2024-2029. Geographically On the basis of several leading and niche products, the market has been expounded,, and. with All the Reason the Market Seeing So Many Inexperienced Joiners without a Donor Vehicle. Whereas before, high entry barriers were powered by technologies and broad availability, which let people get involved in these app-based schemes without experience or donor vehicles..

"Asia Pacific to register highest growth rate in the market during the forecast period."

The highest CAGR is likely to be registered by the APAC region throughout the forecast period from 2024-2029. Asia Pacific is made up of India, China, Japan, South Korea, Australia, and RoAPAC. The Asia-Pacific region has reflected the highest upsurge in the market growth rate for in vitro fertilization.

The majority of the share of in vitro fertilization (IVF) markets in the Asia-Pacific are top for a number of indispensable reasons With a number of important considerations countries in the Asia Pacific region now own the highest share of the in vitro fertilization market. First and foremost, IVF service needs have increased due to rising rates of infertility, commonality in delayed childbearing, and changes in lifestyle. Better infrastructural facilities in healthcare, rising disposable incomes, and increasing awareness about fertility treatments are making more countries across this region accept and procure IVF. Added to these is the development of reproductive technologies and government programs encouraging fertility treatments, which support the growth of the Asia Pacific industry.

A number of drivers were responsible for the upswing, including:

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
  • By Designation: C-level-- 10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-30%, Asia Pacific-22%, Rest of the world-8%

Prominent players in this market are Cooper companies inc.(US), Cook Medical Inc.(US),Vitrolife(Europe), Fujifilm Irvine scientific(Japan),Hamilton thorne ltd.(US), Thermo fisher scientific(US), Nikon corporation(Japan), Olympus(Japan), Kitazato corporation(Japan), Corning incorporated(US), Zeiss group(Europe), Fertipro nv(Europe), Eppendorf(Europe) among others.

Research Coverage

The segmentation is based on products, cycle, procedure, end user, and region. The report analyzes the factors that have been affecting and will affect the growth of the market, including drivers, restraints, opportunities, and challenges. The report details opportunities and challenges in the in vitro fertilization market for stakeholders. Further details on competitive landscapes for market leaders are also provided. This report evaluates micro-markets with respect to the growth trends, prospects, and contributions towards the global in vitro fertilization market. The report expects the revenues of the segments of the market to increase with a view of five major regions.

Key Benefits of Buying the Report:

  • The report intends to help new entrants, it addresses the availability of comprehensive data to help new entrants, top players of the in vitro fertilization market, and small enterprises understand investment viability. It shall aid processes of robust risk assessment and which investment decisions. It offers precise segmentation of markets, like that based on end-users and regional dimensions, hence giving targeted segments tailored insights. It also evaluates the highest trends, challenges, growth drivers, and opportunities for the same, thereby empowering strategic decision-making with insightful judgment.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the in vitro fertilization market: Advanced technology and ageing population of women; high cost of IVF procedures and ethical concerns; growing number of fertility clinics and increased treatment option.They have declined infertility treatment among women of high age.

Product Development/Innovation: Insights into pipeline technologies, research & development activities, and new product & service launches in the in vitro fertilization market.

Market Development: Detailed information about lucrative markets-the report analyses the in vitro fertilization market across varied regions.

Market Diversification: Detailed insight into new products, untapped geographies, recent developments, and investments in the in vitro fertilization market.

Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as CooperSurgical Inc.(US), Vitrolife (Sweden), Cook Medical Inc.(US), Hamilton Thorne (US) and Thermo Fisher Scientific(US) among others.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY RESEARCH
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key industry insights
      • 2.2.2.3 Breakdown of primary interviews
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Company revenue estimation approach
      • 2.3.1.2 Customer-based market estimation
      • 2.3.1.3 Growth forecast approach
      • 2.3.1.4 CAGR projections
  • 2.4 DATA TRIANGULATION
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 GROWTH RATE ASSUMPTIONS
  • 2.8 RESEARCH LIMITATIONS
  • 2.9 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 IN VITRO FERTILIZATION MARKET OVERVIEW
  • 4.2 IN VITRO FERTILIZATION MARKET, BY REGION
  • 4.3 ASIA PACIFIC IN VITRO FERTILIZATION MARKET, BY COUNTRY AND END USER, 2023
  • 4.4 GEOGRAPHIC SNAPSHOT OF IN VITRO FERTILIZATION MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing median age of pregnancy
      • 5.2.1.2 Rising infertility rate
      • 5.2.1.3 Booming fertility industry
      • 5.2.1.4 Evolving technological landscape
      • 5.2.1.5 Favorable government initiatives
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of IVF procedures
      • 5.2.2.2 Social and ethical concerns in developing countries
      • 5.2.2.3 Elevated risk of complications
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging economies
      • 5.2.3.2 Availability of diverse range of fertility treatment options
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Reduced efficacy of infertility treatments for patients of advanced age
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RESEARCH & DEVELOPMENT
    • 5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
    • 5.3.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE TREND, BY REGION
    • 5.5.2 AVERAGE SELLING PRICE TREND OF TOP 3 ACCESSORIES, BY KEY PLAYER
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 THREAT OF SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 PATENT ANALYSIS
  • 5.8 TRADE DATA ANALYSIS
    • 5.8.1 IMPORT DATA
    • 5.8.2 EXPORT DATA
  • 5.9 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.10.2 BUYING CRITERIA
  • 5.11 UNMET NEEDS
  • 5.12 ECOSYSTEM ANALYSIS
  • 5.13 SUPPLY CHAIN ANALYSIS
    • 5.13.1 PROMINENT COMPANIES
    • 5.13.2 SMALL AND MEDIUM-SIZED ENTERPRISES
    • 5.13.3 END USERS
  • 5.14 TECHNOLOGY ANALYSIS
    • 5.14.1 KEY TECHNOLOGIES
      • 5.14.1.1 Time-lapse technology
    • 5.14.2 COMPLEMENTARY TECHNOLOGIES
      • 5.14.2.1 Preimplantation genetic testing
    • 5.14.3 ADJACENT TECHNOLOGIES
      • 5.14.3.1 Sperm cryopreservation
      • 5.14.3.2 Oocyte cryopreservation
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 ENHANCED IVF RATES USING EMBRYOTOXICITY, PLATELET LEUKOCYTE AGGREGATES, AND NATURAL KILLER DIAGNOSIS
  • 5.16 REGULATORY LANDSCAPE
    • 5.16.1 REGULATORY STANDARDS AND APPROVALS
      • 5.16.1.1 North America
        • 5.16.1.1.1 US
        • 5.16.1.1.2 Canada
      • 5.16.1.2 Europe
      • 5.16.1.3 Asia Pacific
        • 5.16.1.3.1 India
        • 5.16.1.3.2 Japan
    • 5.16.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.17 INVESTMENT AND FUNDING SCENARIO
  • 5.18 REIMBURSEMENT SCENARIO
  • 5.19 IMPACT OF GEN AI ON IN VITRO FERTILIZATION MARKET

6 IN VITRO FERTILIZATION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 EQUIPMENT
    • 6.2.1 MICROSCOPES
      • 6.2.1.1 Need for assessing cell division and morphology during embryo development to drive market
    • 6.2.2 IMAGING SYSTEMS
      • 6.2.2.1 Need for real-time monitoring of oocytes and embryos to fuel market
    • 6.2.3 SPERM ANALYZER SYSTEMS
      • 6.2.3.1 Capability to identify fertility problems and determine appropriate interventions to fuel market
    • 6.2.4 OVUM ASPIRATION PUMPS
      • 6.2.4.1 Optimized retrieval of viable eggs and shortened procedure duration to aid growth
    • 6.2.5 MICROMANIPULATOR SYSTEMS
      • 6.2.5.1 Increased adoption in intracytoplasmic sperm injections and embryo biopsies to boost market
    • 6.2.6 INCUBATORS
      • 6.2.6.1 Time-lapse incubators
        • 6.2.6.1.1 Non-invasive techniques to propel market
      • 6.2.6.2 Other incubators
    • 6.2.7 GAS ANALYZERS
      • 6.2.7.1 Ability to replicate natural conditions of human reproductive system to drive market
    • 6.2.8 CRYOSYSTEMS
      • 6.2.8.1 Higher flexibility to use stored embryos, sperm, and eggs to support market growth
    • 6.2.9 LASER SYSTEMS
      • 6.2.9.1 Precise embryo manipulation and observation to augment growth
    • 6.2.10 SPERM SEPARATION SYSTEMS
      • 6.2.10.1 Need to maintain stable and optimal conditions in controlled environment to stimulate segment growth
    • 6.2.11 CABINETS
      • 6.2.11.1 Rising awareness about biological safety of IVF to boost market
    • 6.2.12 ANTI-VIBRATION TABLES
      • 6.2.12.1 Growing need for improved procedural accuracy to fuel market
    • 6.2.13 WITNESS SYSTEMS
      • 6.2.13.1 Rigorous safety and quality assurance standards to stimulate growth
    • 6.2.14 OTHER EQUIPMENT
  • 6.3 REAGENTS & MEDIA
    • 6.3.1 EMBRYO CULTURE MEDIA
      • 6.3.1.1 Enhanced health and viability during embryo culture to aid growth
    • 6.3.2 CRYOPRESERVATION MEDIA
      • 6.3.2.1 Ability to protect cells from damage to drive market
    • 6.3.3 SPERM PROCESSING MEDIA
      • 6.3.3.1 Use in washing, capacitation, and sperm selection applications to boost segment
    • 6.3.4 OVUM PROCESSING MEDIA
      • 6.3.4.1 Ability to mimic natural conditions of female reproductive tract to propel market
  • 6.4 ACCESSORIES
    • 6.4.1 GROWING INCLINATION TOWARD COMFORTABLE IVF PROCEDURE TO SUPPORT GROWTH

7 IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE

  • 7.1 INTRODUCTION
  • 7.2 FRESH NON-DONORS
    • 7.2.1 RISING PREFERENCE FOR TREATMENT AMONG YOUNGER WOMEN TO AUGMENT GROWTH
  • 7.3 FROZEN NON-DONORS
    • 7.3.1 IMPROVED EGG QUALITY AND FLEXIBLE SCHEDULING TO BOOST MARKET
  • 7.4 FROZEN DONORS
    • 7.4.1 GROWING INCLINATION TOWARD READY-TO-USE HEALTHY EGGS TO FUEL MARKET
  • 7.5 FRESH DONORS
    • 7.5.1 HIGHER CHANCE OF FERTILIZATION AND EMBRYO DEVELOPMENT TO PROPEL MARKET

8 IN VITRO FERTILIZATION MARKET, BY PROCEDURE

  • 8.1 INTRODUCTION
  • 8.2 CONVENTIONAL IVF
    • 8.2.1 PROVEN SUCCESS RATE IN ADDRESSING INFERTILITY ISSUES TO DRIVE MARKET
  • 8.3 IVF WITH INTRACYTOPLASMIC SPERM INJECTIONS
    • 8.3.1 HIGHER SUCCESS RATES THAN CONVENTIONAL METHODS TO STIMULATE GROWTH
  • 8.4 MINIMAL IVF
    • 8.4.1 RISING EMPHASIS ON MINIMIZED POTENTIAL SIDE EFFECTS TO SUPPORT MARKET
  • 8.5 IVF WITH DONOR EGGS
    • 8.5.1 ABILITY TO ADDRESS PREMATURE OVARIAN FAILURE OR GENETIC DISORDERS TO AUGMENT GROWTH
  • 8.6 OTHER PROCEDURES

9 IN VITRO FERTILIZATION MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 FERTILITY CLINICS & IVF CENTERS
    • 9.2.1 INCREASED AVAILABILITY AND ACCESSIBILITY TO FUEL MARKET
  • 9.3 HOSPITALS & SURGICAL CENTERS
    • 9.3.1 NEED FOR ADVANCED LABORATORIES FOR GAMETE HANDLING AND ULTRASOUND MONITORING TO FUEL MARKET
  • 9.4 RESEARCH INSTITUTES
    • 9.4.1 ONGOING RESEARCH FOR COST-EFFECTIVE AND ADVANCED TECHNIQUES TO BOOST MARKET
  • 9.5 CRYOBANKS
    • 9.5.1 GROWING INCLINATION TOWARD FLEXIBLE TREATMENT TO AID MARKET GROWTH

10 IN VITRO FERTILIZATION MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 ASIA PACIFIC
    • 10.2.1 CHINA
      • 10.2.1.1 Increasing medical benefits for childbirth to drive market
    • 10.2.2 JAPAN
      • 10.2.2.1 Low fertility rates to support market growth
    • 10.2.3 INDIA
      • 10.2.3.1 Affordable treatment options to fuel market
    • 10.2.4 AUSTRALIA
      • 10.2.4.1 Declining fertility rate to propel market
    • 10.2.5 SOUTH KOREA
      • 10.2.5.1 Growing focus on reversing low population trend to stimulate growth
    • 10.2.6 REST OF ASIA PACIFIC
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Robust healthcare infrastructure to support market growth
    • 10.3.2 UK
      • 10.3.2.1 Growing focus on high-quality care at licensed fertility clinics to propel market
    • 10.3.3 FRANCE
      • 10.3.3.1 Rising age of women at first birth to boost market
    • 10.3.4 ITALY
      • 10.3.4.1 Regulatory guidelines to govern market
    • 10.3.5 SPAIN
      • 10.3.5.1 Booming medical tourism to drive market
    • 10.3.6 REST OF EUROPE
  • 10.4 NORTH AMERICA
    • 10.4.1 US
      • 10.4.1.1 Favorable infrastructure network to drive market
    • 10.4.2 CANADA
      • 10.4.2.1 Growing assistance from banks for fertility treatments to fuel market
  • 10.5 LATIN AMERICA
    • 10.5.1 BRAZIL
      • 10.5.1.1 Decrease in percentage of women under 30 years of age to stimulate growth
    • 10.5.2 MEXICO
      • 10.5.2.1 Growing network of state-of-the-art facilities to aid market growth
    • 10.5.3 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 GCC COUNTRIES
      • 10.6.1.1 Improving health infrastructure and better awareness about fertility treatments to propel market
    • 10.6.2 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN IN VITRO FERTILIZATION MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Product footprint
      • 11.5.5.3 End-user footprint
      • 11.5.5.4 Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • 11.7.2 COMPANY VALUATION
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
    • 11.9.2 DEALS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 COOPERSURGICAL, INC.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Right to win
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 VITROLIFE
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Deals
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Right to win
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 COOK MEDICAL INC.
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches and approvals
        • 12.1.3.3.2 Deals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Right to win
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 HAMILTON THORNE
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Deals
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Right to win
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses and competitive threats
    • 12.1.5 THERMO FISHER SCIENTIFIC INC.
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 MnM view
        • 12.1.5.3.1 Right to win
        • 12.1.5.3.2 Strategic choices
        • 12.1.5.3.3 Weaknesses and competitive threats
    • 12.1.6 FUJIFILM IRVINE SCIENTIFIC
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product launches and approvals
        • 12.1.6.3.2 Other developments
    • 12.1.7 KITAZATO CORPORATION
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Deals
    • 12.1.8 ESCO MICRO PTE. LTD.
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Deals
    • 12.1.9 FERTIPRO NV
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
    • 12.1.10 GENEA BIOMEDX
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Deals
    • 12.1.11 NIKON CORPORATION
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
    • 12.1.12 OLYMPUS
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
    • 12.1.13 CORNING INCORPORATED
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
    • 12.1.14 CARL ZEISS MICROSCOPY GMBH
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
    • 12.1.15 EPPENDORF
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products offered
      • 12.1.15.3 Recent developments
        • 12.1.15.3.1 Deals
    • 12.1.16 MEIJI TECHNO
      • 12.1.16.1 Business overview
      • 12.1.16.2 Products offered
    • 12.1.17 LEICA MICROSYSTEMS
      • 12.1.17.1 Business overview
      • 12.1.17.2 Products offered
    • 12.1.18 GE HEALTHCARE
      • 12.1.18.1 Business overview
      • 12.1.18.2 Products offered
      • 12.1.18.3 Recent developments
        • 12.1.18.3.1 Product launches and approvals
        • 12.1.18.3.2 Deals
  • 12.2 OTHER COMPANIES
    • 12.2.1 BIOIMAGER
    • 12.2.2 ALLWIN MEDICAL DEVICES
    • 12.2.3 SHANGHAI UNICORN MEDICAL TECHNOLOGY
    • 12.2.4 GYNEMED
    • 12.2.5 INVITROCARE
    • 12.2.6 IVFTECH
    • 12.2.7 LABIVF
    • 12.2.8 MONASH BIOTECH
    • 12.2.9 HUNTER SCIENTIFIC
    • 12.2.10 CALIBRE SCIENTIFIC
    • 12.2.11 SHIVANI SCIENTIFIC INDUSTRIES (P) LTD.
    • 12.2.12 MINITUBE HUMAN ART

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 IN VITRO FERTILIZATION MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 AVERAGE SELLING PRICE OF IVF EQUIPMENT, BY REGION, 2023 (USD THOUSAND)
  • TABLE 3 AVERAGE SELLING PRICES OF TOP 3 ACCESSORIES, BY KEY PLAYER, 2023 (USD)
  • TABLE 4 IN VITRO FERTILIZATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 5 INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
  • TABLE 6 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 7 EXPORT DATA FOR HS CODE 902750, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 8 IN VITRO FERTILIZATION MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS (%)
  • TABLE 10 KEY BUYING CRITERIA, BY TOP TWO END USERS
  • TABLE 11 IN VITRO FERTILIZATION MARKET: CURRENT UNMET NEEDS
  • TABLE 12 IN VITRO FERTILIZATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 13 REGULATORY STANDARDS AND APPROVALS FOR IN VITRO FERTILIZATION, BY COUNTRY
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 MAJOR CPT CODES FOR LASER PROCEDURES IN US, 2023
  • TABLE 20 IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 21 IN VITRO FERTILIZATION EQUIPMENT MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 22 IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 23 IN VITRO FERTILIZATION MARKET FOR MICROSCOPES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 24 IN VITRO FERTILIZATION MARKET FOR IMAGING SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 25 IN VITRO FERTILIZATION MARKET FOR SPERM ANALYZER SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 26 IN VITRO FERTILIZATION MARKET FOR OVUM ASPIRATION PUMPS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 27 IN VITRO FERTILIZATION MARKET FOR MICROMANIPULATOR SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 28 IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 29 IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 30 IN VITRO FERTILIZATION MARKET FOR TIME-LAPSE INCUBATORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 31 IN VITRO FERTILIZATION MARKET FOR OTHER INCUBATORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 32 IN VITRO FERTILIZATION MARKET FOR GAS ANALYZERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 33 IN VITRO FERTILIZATION MARKET FOR CRYOSYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 IN VITRO FERTILIZATION MARKET FOR LASER SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 35 IN VITRO FERTILIZATION MARKET FOR SPERM SEPARATION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 IN VITRO FERTILIZATION MARKET FOR CABINETS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 37 IN VITRO FERTILIZATION MARKET FOR ANTI-VIBRATION TABLES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 IN VITRO FERTILIZATION MARKET FOR WITNESS SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 39 IN VITRO FERTILIZATION MARKET FOR OTHER EQUIPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 41 IN VITRO FERTILIZATION MARKET FOR EMBRYO CULTURE MEDIA, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 42 IN VITRO FERTILIZATION MARKET FOR CRYOPRESERVATION MEDIA, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 43 IN VITRO FERTILIZATION MARKET FOR SPERM PROCESSING MEDIA, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 IN VITRO FERTILIZATION MARKET FOR OVUM PROCESSING MEDIA, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 45 IN VITRO FERTILIZATION MARKET FOR ACCESSORIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 46 COMPARISON BETWEEN FRESH AND FROZEN DONOR EGGS
  • TABLE 47 IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022-2029 (USD MILLION)
  • TABLE 48 IN VITRO FERTILIZATION MARKET FOR FRESH NON-DONORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 IN VITRO FERTILIZATION MARKET FOR FROZEN NON-DONORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 50 IN VITRO FERTILIZATION MARKET FOR FROZEN DONORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 IN VITRO FERTILIZATION MARKET FOR FRESH DONORS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 52 IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 53 IN VITRO FERTILIZATION MARKET FOR CONVENTIONAL IVF, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 54 IN VITRO FERTILIZATION MARKET FOR IVF WITH INTRACYTOPLASMIC SPERM INJECTIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 IN VITRO FERTILIZATION MARKET FOR MINIMAL IVF, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 IN VITRO FERTILIZATION MARKET FOR IVF WITH DONOR EGGS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 57 IN VITRO FERTILIZATION MARKET FOR OTHER PROCEDURES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 IN VITRO FERTILIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 59 IN VITRO FERTILIZATION MARKET FOR FERTILITY CLINICS & IVF CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 60 IN VITRO FERTILIZATION MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 61 IN VITRO FERTILIZATION MARKET FOR RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 IN VITRO FERTILIZATION MARKET FOR CRYOBANKS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 63 IN VITRO FERTILIZATION MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: IN VITRO FERTILIZATION FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 69 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022-2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 72 CHINA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 73 CHINA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 74 CHINA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 CHINA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 JAPAN: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 77 JAPAN: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 78 JAPAN: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 79 JAPAN: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 80 INDIA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 81 INDIA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 82 INDIA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 INDIA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 84 AUSTRALIA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 85 AUSTRALIA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 86 AUSTRALIA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 AUSTRALIA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 SOUTH KOREA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 89 SOUTH KOREA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION
  • TABLE 90 SOUTH KOREA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 SOUTH KOREA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 93 REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 94 REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 REST OF ASIA PACIFIC: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 EUROPE: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 97 EUROPE: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 98 EUROPE: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 EUROPE: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 EUROPE: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 EUROPE: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 102 EUROPE: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022-2029 (USD MILLION)
  • TABLE 103 EUROPE: IN VITRO FERTILIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 104 GERMANY: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 105 GERMANY: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 GERMANY: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 GERMANY: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 UK: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 109 UK: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 UK: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 111 UK: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 FRANCE: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 113 FRANCE: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 FRANCE: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 115 FRANCE: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 ITALY: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 117 ITALY: IN VITRO FERTILIZATION FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 118 ITALY: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 ITALY: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 SPAIN: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 121 SPAIN: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 SPAIN: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 SPAIN: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 REST OF EUROPE: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 125 REST OF EUROPE: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 REST OF EUROPE: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 REST OF EUROPE: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 129 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 NORTH AMERICA: IN VITRO FERTILIZATION FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 132 NORTH AMERICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 134 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022-2029 (USD MILLION)
  • TABLE 135 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 136 US: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 137 US: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 US: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 US: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 140 CANADA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 141 CANADA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 142 CANADA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 CANADA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 149 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 150 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022-2029 (USD MILLION)
  • TABLE 151 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 152 BRAZIL: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 153 BRAZIL: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 BRAZIL: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 155 BRAZIL: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 MEXICO: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 157 MEXICO: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 158 MEXICO: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 MEXICO: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 161 REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 REST OF LATIN AMERICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 165 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 166 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY PROCEDURE, 2022-2029 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY TYPE OF CYCLE, 2022-2029 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 172 GCC COUNTRIES: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 173 GCC COUNTRIES: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 GCC COUNTRIES: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 176 REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 177 REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR EQUIPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR INCUBATORS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 REST OF MIDDLE EAST & AFRICA: IN VITRO FERTILIZATION MARKET FOR REAGENTS & MEDIA, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 181 IN VITRO FERTILIZATION MARKET: DEGREE OF COMPETITION
  • TABLE 182 IN VITRO FERTILIZATION MARKET: PRODUCT FOOTPRINT
  • TABLE 183 IN VITRO FERTILIZATION MARKET: END-USER FOOTPRINT
  • TABLE 184 IN VITRO FERTILIZATION MARKET: REGION FOOTPRINT
  • TABLE 185 IN VITRO FERTILIZATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 186 IN VITRO FERTILIZATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 187 IN VITRO FERTILIZATION MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 188 IN VITRO FERTILIZATION MARKET: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 189 COOPERSURGICAL, INC.: COMPANY OVERVIEW
  • TABLE 190 COOPERSURGICAL, INC.: PRODUCTS OFFERED
  • TABLE 191 COOPERSURGICAL, INC.: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 192 VITROLIFE: COMPANY OVERVIEW
  • TABLE 193 VITROLIFE: PRODUCTS OFFERED
  • TABLE 194 VITROLIFE: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 195 COOK MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 196 COOK MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 197 COOK MEDICAL INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 198 COOK MEDICAL INC.: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 199 HAMILTON THORNE: COMPANY OVERVIEW
  • TABLE 200 HAMILTON THORNE: PRODUCTS OFFERED
  • TABLE 201 HAMILTON THORNE: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 202 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 203 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 204 FUJIFILM IRVINE SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 205 FUJIFILM IRVINE SCIENTIFIC: PRODUCTS OFFERED
  • TABLE 206 FUJIFILM IRVINE SCIENTIFIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 207 FUJIFILM IRVINE SCIENTIFIC: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2024
  • TABLE 208 KITAZATO CORPORATION: COMPANY OVERVIEW
  • TABLE 209 KITAZATO CORPORATION: PRODUCTS OFFERED
  • TABLE 210 KITAZATO CORPORATION: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 211 ESCO MICRO PTE. LTD.: COMPANY OVERVIEW
  • TABLE 212 ESCO MICRO PTE. LTD.: PRODUCTS OFFERED
  • TABLE 213 ESCO MICRO PTE. LTD.: DEALS, JANUARY 2021-MARCH 2024
  • TABLE 214 FERTIPRO NV: COMPANY OVERVIEW
  • TABLE 215 FERTIPRO NV: PRODUCTS OFFERED
  • TABLE 216 GENEA BIOMEDX: COMPANY OVERVIEW
  • TABLE 217 GENEA BIOMEDX: PRODUCTS OFFERED
  • TABLE 218 GENEA BIOMEDX: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 219 NIKON CORPORATION: COMPANY OVERVIEW
  • TABLE 220 NIKON CORPORATION: PRODUCTS OFFERED
  • TABLE 221 OLYMPUS: COMPANY OVERVIEW
  • TABLE 222 OLYMPUS: PRODUCTS OFFERED
  • TABLE 223 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 224 CORNING INCORPORATED: PRODUCTS OFFERED
  • TABLE 225 CARL ZEISS MICROSCOPY GMBH: COMPANY OVERVIEW
  • TABLE 226 CARL ZEISS MICROSCOPY GMBH: PRODUCTS OFFERED
  • TABLE 227 EPPENDORF: COMPANY OVERVIEW
  • TABLE 228 EPPENDORF: PRODUCTS OFFERED
  • TABLE 229 EPPENDORF: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 230 MEIJII TECHNO: COMPANY OVERVIEW
  • TABLE 231 MEIJII TECHNO: PRODUCTS OFFERED
  • TABLE 232 LEICA MICROSYSTEMS: COMPANY OVERVIEW
  • TABLE 233 LEICA MICROSYSTEMS: PRODUCTS OFFERED
  • TABLE 234 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 235 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 236 GE HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-JUNE 2024
  • TABLE 237 GE HEALTHCARE: DEALS, JANUARY 2021- JUNE 2024
  • TABLE 238 BIOIMAGER: COMPANY OVERVIEW
  • TABLE 239 ALLWIN MEDICAL DEVICES: COMPANY OVERVIEW
  • TABLE 240 SHANGHAI UNICORN MEDICAL TECHNOLOGY: COMPANY OVERVIEW
  • TABLE 241 GYNEMED: COMPANY OVERVIEW
  • TABLE 242 INVITROCARE: COMPANY OVERVIEW
  • TABLE 243 IVFTECH: COMPANY OVERVIEW
  • TABLE 244 LABIVF: COMPANY OVERVIEW
  • TABLE 245 MONASH BIOTECH: COMPANY OVERVIEW
  • TABLE 246 HUNTER SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 247 CALIBRE SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 248 SHIVANI SCIENTIFIC INDUSTRIES (P) LTD.: COMPANY OVERVIEW
  • TABLE 249 MINITUBE HUMAN ART: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 IN VITRO FERTILIZATION MARKET SEGMENTATION
  • FIGURE 2 IN VITRO FERTILIZATION MARKET: RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 6 IN VITRO FERTILIZATION MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
  • FIGURE 7 IN VITRO FERTILIZATION MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 DATA TRIANGULATION
  • FIGURE 10 GROWTH RATE ASSUMPTIONS
  • FIGURE 11 IN VITRO FERTILIZATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 IN VITRO FERTILIZATION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 IN VITRO FERTILIZATION MARKET, BY REGION, 2024-2029
  • FIGURE 14 RISING INFERTILITY RATES AND EMERGENCE OF IVF PROCEDURES WORLDWIDE TO DRIVE MARKET
  • FIGURE 15 ASIA PACIFIC TO LEAD MARKET IN 2024
  • FIGURE 16 CHINA AND FERTILITY CLINICS & IVF CENTERS SEGMENT DOMINATED MARKET IN 2023
  • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 18 IN VITRO FERTILIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19 IN VITRO FERTILIZATION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS
  • FIGURE 21 AVERAGE SELLING PRICE TREND OF IVF EQUIPMENT, BY REGION, 2023 (USD THOUSAND)
  • FIGURE 22 AVERAGE SELLING PRICE OF TOP 3 ACCESSORIES, BY KEY PLAYER, 2023 (USD)
  • FIGURE 23 PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 24 PATENT ANALYSIS, JANUARY 2013- DECEMBER 2023
  • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO END USERS
  • FIGURE 26 KEY BUYING CRITERIA, BY TOP TWO END USERS
  • FIGURE 27 IN VITRO FERTILIZATION MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 28 IN VITRO FERTILIZATION MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 29 INVESTMENT AND FUNDING SCENARIO, 2018-2022
  • FIGURE 30 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022
  • FIGURE 31 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018-2022 (USD MILLION)
  • FIGURE 32 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET SNAPSHOT
  • FIGURE 33 REVENUE ANALYSIS OF TOP PLAYERS IN IN VITRO FERTILIZATION MARKET, 2019-2023 (USD MILLION)
  • FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 35 RANKING OF KEY PLAYERS IN IN VITRO FERTILIZATION MARKET, 2023
  • FIGURE 36 IN VITRO FERTILIZATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 37 IN VITRO FERTILIZATION MARKET: COMPANY FOOTPRINT
  • FIGURE 38 IN VITRO FERTILIZATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 39 EV/EBITDA OF KEY VENDORS
  • FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 41 IN VITRO FERTILIZATION MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 42 COOPERSURGICAL, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 43 VITROLIFE: COMPANY SNAPSHOT (2023)
  • FIGURE 44 HAMILTON THORNE: COMPANY SNAPSHOT (2023)
  • FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 46 FUJIFILM IRVINE SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 47 NIKON CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 48 OLYMPUS: COMPANY SNAPSHOT (2023)
  • FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 50 CARL ZEISS MICROSCOPY GMBH: COMPANY SNAPSHOT (2022)
  • FIGURE 51 EPPENDORF: COMPANY SNAPSHOT (2023)
  • FIGURE 52 GE HEALTHCARE: COMPANY SNAPSHOT (2023)